ASCO Direct: Oncology Breakthrough where Science meets Technology
Event Information
About this Event
Conference Agenda
- M/C: Minghua Lu, MBA, Managing Partner, eChinaHealth
8:30-8:50: Registration
8:50-9:00: Opening Remarks
- Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute
- Ruilin Song, LLB, MBA, PhD, Chairman, China Pharmaceutical Innovation and Research Development Association (PhIRDA)
9:00-9:45: The Next Big Thing in Oncology
- Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute
9:45-10:30: How Technology Will Shape the Future of Cancer Care
- Steve Q. Yang, PhD, EVP and CBO, WuXi AppTec
10:30-11:00: Coffee Break
11:00-12:00: Panel Discussion: The Next Big Thing in Oncology
Panel Chair:
- George W. Sledge Jr., MD, FASCO, Professor, Medicine and Oncology, and Chief of the Division of Oncology, Stanford University Medical Center
Panelists:
- Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute
- Steve Q. Yang, PhD, EVP and CBO, WuXi AppTec
- Alex Casdin, MBA, CEO of Reneo Capital Management
12:00-1:30: Lunch
1:30-:1:50: AI in Discovering Hypothesis & Drug Repurposing
- Bob Battista, MBA, FRCPH, FRCP Edin, Chief Executive Officer, Doctor Evidence
1:50-:2:50: Panel Discussion: AI Healthcare
Panel Chair:
- Bob Battista, MBA, FRCPH, FRCP Edin, Chief Executive Officer, Doctor Evidence
Panelists:
- Bernard Hamelin, MD, MSc, MBA, Global Head of Medical Evidence Generation, Sanofi
- Jonathan Usuka, MBA, PhD, Leader, the Center for Analytics and Real World Evidence (CARE) for the Pharmaceutical & Medical Products practice, McKinsey & Company
- Mir Sohail Fazeli, MD, PhD, President and Managing Director, Evidinno Outcomes Research
2:50-3:10: Overview of Robotic Surgery
- Steven J. Shichman, MD, Physician in Chief, Tallwood Urology and Kidney Institute, Hartford HealthCare
3:10-4:10: Panel Discussion: Robotic Surgery
Panel Chair:
- Steven J. Shichman, MD, Physician in Chief, Tallwood Urology and Kidney Institute, Hartford HealthCare
Panelists: Senior executives of below corporations
- Gary Guthart, Ph.D, CEO, Intuitive Surgical
- Kurt Azarbarzin, President and CEO, VERB Surgical
- Bob White, MBA, Executive VP and President, Minimally Invasive Therapies Group, Medtronic
- Martin Frost, Director and Co-Founder, CMR Surgical
4:10-4:30: Coffee Break
4:30-6:00: Panel Discussion: Harnessing Technology for Innovative Cancer Care Delivery
Panel Chair:
- Yan Li, MD, Hematology/Oncology Department Chief, Kaiser Permanente Hospital
Real World Data from Real World Patients: A Technological Collaboration between Kaiser Permanente and the US FDA
- Piyush Srivastava, MD, Hematology/Oncology, Kaiser Permanente Hospital
Using Technology to Optimize Clinical Trial Engagement
- Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute
Technological Solutions most needed by Industry for Drug Development
- Geoff Kim, MD, Vice President, Applied Innovation, BeiGene
Using Telehealth to Provide Virtual Hematology Consultation
- Ashok Pai, MD, Clinical Leader of Benign Hematology, Kaiser Permanente
6:00-7:30: Evening Reception